Healthcare - Biotechnology - NASDAQ - US
$ 0.85
-0.117 %
$ 51.3 M
Market Cap
-0.49
P/E
BALANCE SHEET
213 M
ASSETS
54.2 M
LIABILITIES
159 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Kronos Bio, Inc.
| Current Assets | 179 M |
| Cash & Short-Term Investments | 173 M |
| Receivables | 0 |
| Other Current Assets | 5.78 M |
| Non-Current Assets | 34.5 M |
| Long-Term Investments | 1.99 M |
| PP&E | 29.9 M |
| Other Non-Current Assets | 2.6 M |
| Current Liabilities | 24.7 M |
| Accounts Payable | 883 K |
| Short-Term Debt | 5.79 M |
| Other Current Liabilities | 18 M |
| Non-Current Liabilities | 29.5 M |
| Long-Term Debt | 25.4 M |
| Other Non-Current Liabilities | 4.13 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 64.3 | 76.0 | 339.5 | 462.1 | 32.6 | 10.2 |
| Short Term Investments | 108.7 | 162.2 | 141.2 | 165.1 | 59.6 | 0 |
| Receivables | 0 | 0.6 | 0.8 | 0.6 | 0 | 0 |
| Inventory | 0 | (10.3) | (0.8) | (49.6) | (0.2) | 0 |
| Other Current Assets | 5.8 | 5.5 | 6.7 | 5.9 | 1.1 | 0.3 |
| Total Current Assets | 178.8 | 244.3 | 347.6 | 419.8 | 93.3 | 10.5 |
| PP&E | 29.9 | 37.7 | 41.8 | 41.0 | 4.2 | 1.8 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 2.0 | 9.8 | 2.0 | 49.0 | 4.8 | 0 |
| Other Long Term Assets | 2.6 | 3.2 | 0.1 | 2.2 | 0.4 | 0.3 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 213.3 | 294.9 | 391.5 | 512.0 | 102.7 | 12.6 |
| LIABILITIES | ||||||
| Accounts Payable | 0.9 | 5.0 | 1.0 | 4.5 | 1.5 | 0.8 |
| Short Term Debt | 5.8 | 4.7 | 4.2 | 0.9 | 0.3 | 0.3 |
| Other Current Liabilities | 8.3 | 11.7 | 8.4 | 6.8 | 0.8 | 0.2 |
| Total Current Liabilities | 24.7 | 21.5 | 13.6 | 12.9 | 2.7 | 1.3 |
| Long Term Debt | 25.4 | 28.7 | 31.7 | 31.1 | 0.2 | 0.5 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0.2 | 1.1 | 2.5 | 123.0 | 18.1 |
| Total Liabilities | 54.2 | 50.4 | 46.4 | 46.4 | 125.9 | 19.9 |
| EQUITY | ||||||
| Common Stock | 59 K | 57 K | 56 K | 54 K | 6 K | 5 K |
| Retained Earnings | (508.9) | (396.2) | (263.0) | (111.9) | (23.5) | (7.3) |
| Other Accumulative Comprehensive Income/Loss | 19 K | (0.8) | 39 K | 19 K | 18 K | (18.0) |
| Total Equity | 159.1 | 244.5 | 345.1 | 465.5 | (23.2) | (7.3) |
| Total Liabilities and Equity | 213.3 | 294.9 | 391.5 | 512.0 | 102.7 | 12.6 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 57.7 | 56.2 | 54.8 | 54.1 | 53.0 | 28.5 |